Department of Orthopaedic Surgery and Sports Medicine, Erasmus MC University Medical Center, Rotterdam 3015GD, the Netherlands; Department of General Practice, Erasmus MC University Medical Center, Rotterdam 3015GD, the Netherlands; Department of Sports Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China.
Department of General Practice, Erasmus MC University Medical Center, Rotterdam 3015GD, the Netherlands.
J Sport Health Sci. 2024 Mar;13(2):256-263. doi: 10.1016/j.jshs.2023.03.007. Epub 2023 Mar 23.
BACKGROUND: Achilles tendinopathy (AT) is a common problem among runners. There is only limited evidence for risk factors for AT, and most studies have not defined the AT subcategories. No study has compared the incidence and risk factors between insertional AT and midportion AT, though they are considered distinct. This study aimed to assess incidence and risk factors of AT based on data from a large prospective cohort. The secondary aim was to explore differences in risk factors between insertional and midportion AT. METHODS: Participants were recruited from among registered runners at registration for running events. Questionnaires were completed at baseline, 1 month before the event, 1 week before the event, and 1 month after the event. Information concerning demographics, training load, registered events, and running-related injuries were collected at baseline. The follow-up questionnaires collected information about new injuries. A pain map was used to diagnose midportion and insertional AT. The primary outcome was the incidence of AT. Multivariable logistic regression analysis was applied to identify risk factors for the onset. RESULTS: We included 3379 participants with a mean follow-up of 20.4 weeks. The incidence of AT was 4.2%. The proportion of insertional AT was 27.7% and of midportion AT was 63.8%; the remaining proportion was a combined type of insertional and midportion AT. Men had a significantly higher incidence (5%, 95% confidence interval (95%CI): 4.1%-6.0%) than women (2.8%, 95%CI: 2.0%-3.8%). AT in the past 12 months was the most predominant risk factor for new-onset AT (odds ratio (OR) = 6.47, 95%CI: 4.27 -9.81). This was similar for both subcategories of AT (insertional: OR = 5.45, 95%CI: 2.51-11.81; midportion: OR = 6.96, 95%CI: 4.24-11.40). Participants registering for an event with a distance of 10/10.55 km were less likely to develop a new-onset AT (OR = 0.59, 95%CI: 0.36-0.97) or midportion AT (OR = 0.47, 95%CI: 0.23 -0.93). Higher age had a significant negative association with insertional AT (OR = 0.97, 95%CI: 0.94-1.00). CONCLUSION: The incidence of new-onset AT among recreational runners was 4.2%. The proportion of insertional and midportion AT was 27.7% and 63.8%, respectively. AT in the past 12 months was the predominant risk factor for the onset of AT. Risk factors varied between insertional and midportion AT, but we could not identify clinically relevant differences between the 2 subtypes.
背景:跟腱病(Achilles tendinopathy,AT)是跑者中常见的问题。尽管大多数研究未对 AT 亚类进行定义,但针对 AT 的风险因素仅有有限的证据。尽管插入性 AT 和中段 AT 被认为是不同的,但尚无研究比较它们的发病率和风险因素。本研究旨在根据大型前瞻性队列研究的数据评估 AT 的发病率和风险因素。次要目的是探讨插入性和中段 AT 之间风险因素的差异。
方法:参与者是在注册跑步活动时从注册跑者中招募的。在基线、活动前 1 个月、活动前 1 周和活动后 1 个月完成问卷调查。基线时收集人口统计学、训练负荷、注册活动和与跑步相关的受伤信息。随访问卷收集新伤信息。疼痛图用于诊断中段和插入性 AT。主要结局是 AT 的发病率。多变量逻辑回归分析用于确定发病的风险因素。
结果:我们纳入了 3379 名参与者,平均随访 20.4 周。AT 的发病率为 4.2%。插入性 AT 的比例为 27.7%,中段 AT 的比例为 63.8%;其余比例为插入性和中段 AT 的混合型。男性的发病率明显高于女性(5%,95%置信区间(95%CI):4.1%-6.0% 比 2.8%,95%CI:2.0%-3.8%)。过去 12 个月的 AT 是新发 AT(优势比(OR)=6.47,95%CI:4.27-9.81)的最主要危险因素。对于两种 AT 亚类,这一情况均类似(插入性:OR=5.45,95%CI:2.51-11.81;中段:OR=6.96,95%CI:4.24-11.40)。参加 10/10.55 公里距离的赛事的参与者发生新发 AT(OR=0.59,95%CI:0.36-0.97)或中段 AT(OR=0.47,95%CI:0.23-0.93)的可能性较低。年龄较大与插入性 AT(OR=0.97,95%CI:0.94-1.00)呈显著负相关。
结论:在娱乐性跑者中,新发 AT 的发病率为 4.2%。插入性和中段 AT 的比例分别为 27.7%和 63.8%。过去 12 个月的 AT 是 AT 发病的主要危险因素。风险因素在插入性和中段 AT 之间存在差异,但我们无法确定两种亚型之间存在有临床意义的差异。
J Sport Health Sci. 2024-3
Scand J Med Sci Sports. 2020-10
Foot Ankle Int. 2008-7
Knee Surg Sports Traumatol Arthrosc. 2015-9
Lakartidningen. 2022-3-15
J Orthop Res. 2025-7
Nat Rev Dis Primers. 2025-3-27
Adv Sci (Weinh). 2024-12
J Sci Med Sport. 2022-3
Br J Sports Med. 2021-10
BMJ Open Sport Exerc Med. 2021-3-26
Scand J Med Sci Sports. 2020-10
BMJ Open Sport Exerc Med. 2020-6-16